2. Academic Validation
  3. Retraction notice to "Enalapril/lercanidipine combination on markers of cardiovascular risk: a randomized study": J Am Soc Hypertens 8 (2014) 422-428

Retraction notice to "Enalapril/lercanidipine combination on markers of cardiovascular risk: a randomized study": J Am Soc Hypertens 8 (2014) 422-428

  • J Am Soc Hypertens. 2015 Oct;9(10):822. doi: 10.1016/j.jash.2015.08.013.
Giuseppe Derosa 1,  Aldo Bonaventura 2,  Davide Romano 2,  Lucio Bianchi 2,  Elena Fogari 2,  Angela D'Angelo 2,  Pamela Maffioli 2
Affiliations

Affiliations

  • 1 Department of Internal Medicine and Therapeutics, University of Pavia and Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy; Center for the Study of Endocrine-Metabolic Pathophysiology and Clinical Research, University of Pavia, Pavia, Italy.
  • 2 Department of Internal Medicine and Therapeutics, University of Pavia and Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy.
PMID: 30153106 DOI: 10.1016/j.jash.2015.08.013
Figures
Products